Does Inhibition of Aldose Reductase Contribute to the Anti-Inflammatory Action of Setipiprant?

    August 2017 in “ Physiological Research ”
    Jana Balleková, M Soltesova-Prnova, Magdaléna Májeková, Milan Štefek
    Image of study
    TLDR Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.
    The study from 2017 investigated setipiprant's potential mechanism of action and found that it inhibits aldose reductase, an enzyme involved in inflammation. This inhibition was demonstrated through spectrophotometric assays and molecular modeling, which showed setipiprant's interaction with the enzyme's inhibitor binding site. The findings suggest that aldose reductase inhibition could contribute to setipiprant's anti-inflammatory effects, which may be beneficial for treating conditions like asthma and androgenic alopecia. However, the study was based on biochemical assays and molecular modeling, and did not involve human or animal subjects, indicating that further experimental research is needed to validate these results.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 28 results

      community Setipiprant trial results

      in Update  11 upvotes 5 years ago
      Setipiprant trial for hair loss failed, showing no difference between placebo and treatment. Discussion also noted placebo users reporting side effects.

      community SETIPIPRANT PGE2 GROUP BUY AND PIONEERING HAIR GROWTH

       7 upvotes 8 years ago
      The conversation is about a user seeking help with hair regrowth treatments, specifically mentioning Setipiprant, Minoxidil, Finasteride, and RU58841. The user is trying to contact forum members for guidance on making and using these treatments.

      community Upcoming Setipiprant clinical trials hint at systemic daily dosage

       21 upvotes 8 years ago
      The conversation discusses the safety, tolerability, and efficacy of oral Setipiprant tablets for treating androgenetic alopecia compared to finasteride. It mentions the high cost of Setipiprant on the black market and the trial's end date in September 2017.

      community Allergan recruiting for Setipiprant trial in the US

       12 upvotes 7 years ago
      The conversation discusses a clinical trial for Setipiprant in the US, starting June 29th, with eligibility excluding recent users of minoxidil or finasteride. It encourages informed decision-making before signing up.

      community Is hair cloning and setipiprant coming in 2020?

      in Question  6 upvotes 8 years ago
      The conversation discusses potential hair loss treatments, including hair cloning, setipiprant, and topical finasteride, questioning their availability and effectiveness as permanent cures. The user is inquiring about the release dates and efficacy of these treatments.

    Related Research

    1 / 1 results